Stem cell treatments usually involve sucking out some of a patients fat tissue, isolating the stem cells within, and reinjecting them into the patients body.
On the first Saturday of March, Kristin Comella put on a white doctors coat and took the stage at the fourth annual conference for the Academy of Regenerative Practices. The founder and president of the academy, Comella also oversees an expanding empire of stem cell clinics that promise patients cures for most anything that ails them. None of those treatmentsfor everything from diabetes and asthma to multiple sclerosis and arthritishave been approved by the US Food and Drug Administration.
The procedurewhich costs a few thousand dollarsis always pretty much the same, regardless of its purported target. It involves sucking out some of a patients fat tissue with a liposuction needle, isolating the stem cells within, and reinjecting them into the patients body. The simplicity of the procedure is why people like Comella say its insane for the FDA to try to regulate stem cells.
So it was surprising when she announced onstage that her firm, US Stem Cell, had recently begun developing a radically new kind of treatmentthis time, for cancer.
Your stem cells are antigen-presenting cells, Cormella told the audience, in a Facebook live video the company posted of the event. We can make them express a protein from your specific cancer. So, its an individualized cancer vaccine, if you will. US Stem Cell, a publicly traded firm that sells stem cell separation kits and operates one of the largest networks of clinics in the country, achieved this with something called an electroporation protocol, she said.
Electroporation is essentially zapping cells with electricitya microbiology technique used to get drugs, proteins, or, most commonly, DNA into cells. When I hear electroporation, thats equal to genetic modification, says Paul Knoepfler, a stem cell researcher at UC Davis. Thats what we do when we want cells to permanently express a protein.
Knoepfler writes a blog about stem cells, and thats where he surfaced the video on May 9, after an acquaintance tipped him off. Hes sort of a watchdog for the industry. Since 2011, hes tracked the proliferation of unregulated stem cell clinics and followed US Stem Cells cavalier approach to experimenting on its patients, sometimes to disastrous effect. In 2015, one of its clinics injected liposuction-derived stem cells directly into the eyeballs of three elderly women suffering from age-related macular degeneration. All three went blind, two sued, and US Stem Cell settled out of court.
But this, he says, might be the most dangerous thing hes seen yet. If my assumption is correct that theyre introducing DNA, this is up near the top of the riskiest things Ive ever heard a stem cell clinic doing, he says. The big worry here is giving cancer patients another cancer, or a dangerous immune response."
US Stem Cell did not respond to WIREDs questions about the procedure, so its still unclear if it does indeed involve genetic modification and whether any patients have actually been treated with it. In the video Comella only described it as one of the companys current protocols.
What we do know is that the approach sounds similar to a powerful new class of anti-cancer medicines known as CAR-T therapies. They involve extracting a patients immune cells and genetically rewiring them to more effectively recognize and attack cancerous cells in the body. The FDA approved the first CAR-T, Kymriah, in late 2017 after scrutinizing years of data from animal studies and human clinical trials. Novartis claims it spent $1 billion to get the treatment to market.
Compare that with the $6,664 US Stem Cell reported having spent last year on research and development. The companyformerly named Biohearthas nine clinical trials listed on the national registry ClinicalTrials.gov, none of which are actively recruiting and none of which are for cancer treatments. Though listed as the lead investigator on some of the trials, Comella isnt a medical doctor. She received a three-year online PhD in stem cell biology from the Panama College of Cell Sciencea non-accredited virtual university founded by stem cell evangelist Walter Drake, according to reporting by the LA Times. And shes not afraid to spar with the federal government.
Last August the FDA sent a warning letter to US Stem Cell and to Comella, specifically, for significant deviations from good practices. And after Comella responded with a letter of her own, denying FDA has any jurisdiction to regulate her companys activities, the agency followed up with a lawsuit.
On May 9, the FDA along with the Department of Justice filed a complaint seeking a permanent injunction against US Stem Cell and Comella, accusing them of endangering patient safety and failing to meet manufacturing standards for cell therapies. The federal officials also filed a similar lawsuit against another clinicCalifornia Stem Cell Treatment Centerwhich was involved in giving patients an experimental cancer treatment made from a mix of stem cells and a smallpox vaccine inappropriately acquired from a Centers for Disease Control and Prevention stockpile under the auspices of research. When officials found out they were being administered to patients, US marshals raided the clinic and seized the remaining vials.
Both California Stem Cell Treatment Center and US Stem Cell said in public statements they plan to fight the injunctions, the most aggressive volley yet in the conflict surrounding direct-to-consumer stem cell treatments. At the heart of the clash is the phrase minimally manipulated, which the FDA uses to exempt therapies like bone marrow transplants. Both clinics will likely argue in court that their cell-based treatments fit that description. But Comellas recent statements at the conference could undermine this claim. Electroporation is a tool designed explicitly for cellular manipulation, and theres nothing minimal about it.
See the original post here:
Is This Stem-Cell Clinic Really Making Cancer Vaccines ...
- Judge Says FDA Can Stop Clinic from Selling Stem Cell ... - May 21st, 2020
- Saad Z. Usmani, on the Approval of Daratumumab and Hyaluronidase-fihj - Cancer Network - May 19th, 2020
- R3 Stem Cell International Now Offering Enhanced Autism Stem Cell Program in Mexico - PR Web - May 19th, 2020
- Stem Cell Concentration System Market Report 2020: Rising Impressive Business - News by aeresearch - May 19th, 2020
- Precision therapy approach secures small biotech $42M haul to combat disease that inspired the Ice Bucket Challenge - Endpoints News - May 19th, 2020
- QurAlis raises $42 Million Series A Financing to Develop New Therapies for Amyotrophic Lateral Sclerosis (ALS) - Business Wire - May 17th, 2020
- Coronavirus Outbreak: Cancer Stem Cell Therapy Market Overview and Competitive Landscape 2020 to 2025 - Cole of Duty - May 15th, 2020
- Intellia Therapeutics Reports Progress on CRISPR/Cas9 AML Cancer Therapy Using Proprietary Cell Engineering Process at the 23rd Annual Meeting of the... - May 12th, 2020
- Vasomune Therapeutics Announces Clinical and Scientific Advisory Board - BioSpace - May 12th, 2020
- Orgenesis sees 1Q revenue rocket driven by its Cell and Gene Therapy Biotech platform - Proactive Investors USA & Canada - May 12th, 2020
- Orgenesis First Quarter 2020 Revenue Increases 348% to $1.9 Million Reflecting Success of CGT Biotech Platform - GlobeNewswire - May 12th, 2020
- Meat the Future - documentary Channel - CBC.ca - May 10th, 2020
- Researchers discover stem cells' 'death-defying' quality that aids healing - ETHealthworld.com - May 10th, 2020
- On the Road As a Stem Cell Courier - CSRwire.com - May 3rd, 2020
- You could be someones only hope: A stem cell donor campaigning to beat blood cancer - Evening Standard - May 3rd, 2020
- David C. Karli is Offering a New Ray of Hope Through Regenerative Medicine - RESPECT. - May 3rd, 2020
- FDA Expediting Accelerated Development of Novel Therapies for COVID-19 - PR Newswire UK - May 3rd, 2020
- What to do if you think you have COVID-19: a step by step guide - The Dickinson Press - April 21st, 2020
- Stem cells in the clinic: how are they regulated? - European Pharmaceutical Review - April 20th, 2020
- NHS's oldest IVF clinic at risk of closure amid increasing privatisations - The Guardian - April 20th, 2020
- Here are the drugs that could treat coronavirus. But don't expect a silver bullet. - The Philadelphia Inquirer - April 18th, 2020
- Analyzing the Outcomes With Different Treatment Techniques in Myeloma - Targeted Oncology - April 18th, 2020
- Team to Advance Stem Cell Therapies in New Space Station Lab - Lab Manager Magazine - April 11th, 2020
- Hackensack Meridian Health Studying the Blood of COVID-19 Survivors - P&T Community - April 11th, 2020
- UC San Diego to Advance Stem Cell Therapies in New Space Station Lab - UC San Diego Health - April 9th, 2020
- Orgenesis partners with Belgium"s RevaTis to develop stem cells for therapeutic use - Proactive Investors USA & Canada - April 9th, 2020
- AgeX Therapeutics Reports Fourth Quarter and Annual 2019 Financial Results and Provides Business Update - Yahoo Finance - March 31st, 2020
- Larkhall mum was walked down the aisle by stem cell donor who saved her life - Daily Record - March 31st, 2020
- Q&A: Covid-19 and impact on people with cancer - The Irish Times - March 30th, 2020
- COVID-19 and Cancer: What You Need to Know - Everyday Health - March 30th, 2020
- Cancer Stem Cell Therapy Value Projected to Expand by 2019-2025 - Monroe Scoop - March 27th, 2020
- Unlocking the Potential of a Widely Used Drug - Technology Networks - March 25th, 2020
- Cancer Care and COVID-19 in Seattle, the First US Epicenter - Medscape - March 24th, 2020
- Immatics and Molmed become the subjects of very different deals - Vantage - March 21st, 2020
- Claudia Rodrigues is removed from the clinic where she was hospitalized because of the coronavirus - Crypto Dictation - March 21st, 2020
- Stem cells can reverse damage caused by heart attack; repair mechanism discovered: Study - International Business Times, Singapore Edition - March 16th, 2020
- Newly Discovered Memory in Our Bones: Keeping a Record of Previous Infections to Boost Immunity - SciTechDaily - March 16th, 2020
- The race to find a coronavirus treatment: One strategy might be just weeks away, scientists say - USA TODAY - March 16th, 2020
- Cancer Stem Cell Therapy Market Global Size, Demand-sales, Suppliers by Key Applications 2019 Detailed Analysis and Growth Aspects on Manufacturing... - March 15th, 2020
- Woman meets stranger who saved her life and allowed her to become a mum - Mirror Online - March 15th, 2020
- Stem Cell Manufacturing Market Analysis By Recent Trends, Developments In Top Manufacturing Technology And Regional Growth Overview And Forecast To... - March 11th, 2020
- Kuur Therapeutics Launches to Develop and Commercialize Off-the-shelf CAR-NKT Cell Therapies Targeting Hematological and Solid Tumors | DNA RNA and... - March 11th, 2020
- The London Patient, Cured of H.I.V., Reveals His Identity - The New York Times - March 11th, 2020
- Cancer Stem Cell Therapy Market 2019- Emerging Economies Expected to Influence Growth by 2025 with Major Players-AVIVA BioSciences, AdnaGen, Advanced... - March 10th, 2020
- Maryland Booms in the BioCapital Hotbed - BioSpace - March 10th, 2020
- Gilead to Acquire Immuno-Oncology Company Forty Seven for $4.9 Billion - PharmaLive - March 5th, 2020
- THC Could Be First-of-its-Kind Treatment for Women With Endometriosis, Says New Study - Good News Network - March 5th, 2020
- Autolus Therapeutics Plc (AUTL) QEarnings Call Transcript - Motley Fool - March 5th, 2020
- CytoDyn Treats First Patient with Leronlimab in Phase 2 Trial for GvHD under Modified Trial Protocol - Yahoo Finance - March 5th, 2020
- Magenta Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Business Highlights - Yahoo Finance - March 4th, 2020
- Omeros Corporation Reports Fourth Quarter and Year-End 2019 Financial Results - Business Wire - March 4th, 2020
- Animal Stem Cell Therapy Market by Segmentation Based on Product, Application and Region, 2019-2025 - Jewish Life News - February 29th, 2020
- Indiana Regenerative Medicine Institute Offers Innovative Approaches in Regenerative Medicine, Hormone Replacement and Pain Management - Zionsville... - February 29th, 2020
- Hyperbaric chamber therapy: Im under a lot of pressure and I love it! - The Guardian - February 25th, 2020
- DDP and Austin Aries Reportedly Pitching Stem Cell Venture to AEW | 411MANIA - 411mania.com - February 25th, 2020
- Why Austin Aries and Raven Were At AEW Dynamite - PWMania - February 25th, 2020
- Austin Aries Confirms Why He Was At AEW Dynamite This Week - 411mania.com - February 24th, 2020
- BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2019 Conference Call and Webcast @ 8:00 am Eastern... - February 18th, 2020
- Animal Stem Cell Therapy Market Projected to Witness Vigorous Expansion by 2017 2025 - Instant Tech News - February 18th, 2020
- 6 Healthcare Stocks That Could Make You Filthy Rich - The Motley Fool - February 18th, 2020
- Mixed ethnic backgrounds make it that much harder to find a bone marrow transplant - MLive.com - February 17th, 2020
- 48% of Couples Are Making This Financial Mistake - Nasdaq - February 17th, 2020
- 'Loving life': 4-year-old not letting heart condition slow him down - Port Clinton News Herald - February 15th, 2020
- Cancer Stem Cell Therapy Market Trends, Key Players, Overview, Competitive Breakdown and Regional Forecast by 2025 Mathematics Market Methods - Keep... - February 15th, 2020
- Regenexx, First to Use Stem Cells in Orthopedic Therapy, Marks 15th Anniversary - Yahoo Finance - February 12th, 2020
- What Drives the Domino Effect in Cancer Drug Resistance? - Technology Networks - February 12th, 2020
- CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019 - Xconomy - February 12th, 2020
- Science team designs a new CAR they say may work much better than BCMAs in fighting multiple myeloma - Endpoints News - February 12th, 2020
- Omeros: 2 Major Catalysts On The Horizon - Seeking Alpha - February 10th, 2020
- Blood In The Joint - Economic Times - February 10th, 2020
- PRACTICALLY ACTIVE: Screening is a smart way to start a healthier life - NWAOnline - February 10th, 2020
- Anemia: Causes, symptoms and treatment - Livescience.com - February 6th, 2020
- Here's Why CRISPR Stocks Fell in January - The Motley Fool - February 6th, 2020
- Victoria Beckham says this product is the best product you will ever use - Marie Claire UK - February 6th, 2020
- Korzan: On World Cancer day, pledge to be relentless - AberdeenNews.com - February 5th, 2020
- Global Radiation Therapy Market to Reach US$ 8.6 bn by 2026, Product Approvals to Drive Growth: Transparency Market Research - PRNewswire - February 5th, 2020
- SASpine to offer Stem Cell Therapy - Yahoo Finance - February 4th, 2020
- Dr. Kenneth Pettine Announces Verification of Clinical Safety Trial - Yahoo Finance - February 4th, 2020
- The Marsh Presents Welcome to The Cancer Caf - Patch.com - February 4th, 2020
- Freeport stem cell therapy provider Okyanos in wind-up petition battle - EyeWitness News - February 4th, 2020